🟢 MiniMed Group is trading 5% up today after Q1 earnings beat and raised FY2027 outlook

MiniMed Group is trading 5.36% up now at $21.34 after a first-quarter earnings beat and outlook upgrade.

• September 1, 2026, results showed $843 million in revenue, up 16.6% year over year, supported by strong U.S. pump growth and the MiniMed Flex launch.
• Management raised FY2027 organic revenue-growth guidance to approximately 10.5% from 10%; breakeven GAAP EPS missed expectations.